Cargando…
Expression of ICOSL is associated with decreased survival in invasive breast cancer
BACKGROUND: Inducible co-stimulator (ICOS) is a CD28-related molecule exclusively expressed on activated T cells and plays a critical role in modulating the immune response in breast cancer. The blockage of ICOS pathway has been shown to inhibit the activity of Type 2 T helper cells, thus potentiall...
Autores principales: | Wang, Bin, Jiang, Huayong, Zhou, Tingyang, Ma, Ning, Liu, Wei, Wang, Yajie, Zuo, Li |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
PeerJ Inc.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6526018/ https://www.ncbi.nlm.nih.gov/pubmed/31143539 http://dx.doi.org/10.7717/peerj.6903 |
Ejemplares similares
-
Phosphorylated-p38 mitogen-activated protein kinase expression is associated with clinical factors in invasive breast cancer
por: Wang, Bin, et al.
Publicado: (2016) -
Loss of human ICOSL results in combined immunodeficiency
por: Roussel, Lucie, et al.
Publicado: (2018) -
Osteopontin binds ICOSL promoting tumor metastasis
por: Raineri, Davide, et al.
Publicado: (2020) -
The ICOS–ICOSL pathway tunes thymic selection
por: Dong, Mengqi, et al.
Publicado: (2022) -
The ICOSL Expression Predicts Better Prognosis for Nasopharyngeal Carcinoma via Enhancing Oncoimmunity
por: Zhang, Geng, et al.
Publicado: (2020)